FLI-1 was utilized to label Ewing's sarcoma or proto-neuroectodermal tumors, with specificity and sensitivity superior to CD99. It is also a novel vascular endothelial marker, and its specificity and sensitivity are also better than those of CD31 and CD34.Its positive site is located in the nucleus, and easy to observe.
[As Figure shows]
Intrauterine endovascular tumor tissue stained with FLI-1
FLI-1 was utilized to label Ewing’s sarcoma or proto-neuroectodermal tumors, with specificity and sensitivity superior to CD99. It is also a novel vascular endothelial marker, and its specificity and sensitivity are also better than those of CD31 and CD34.Its positive site is located in the nucleus, and easy to observe.
Product Name | FLI-1(MRQ-1),MMab |
Catalog No. | CFM-0040 |
Intended Use | IVD, RUO |
Species Reactivity | Human; others not tested |
Cellular Localization | Cytoplasm / Nucleus |
Antibody Type | Mouse Monoclonal |
Clone | MRQ-1 |
Format and Volume | Ready-to-use: 1mL, 3mL, 6mL Concentrated: 0.1mL, 0.2mL and 1mL |
IVD Datasheet (IFU) | ↕️ Download |
RUO Datasheet (IFU) | ↕️ Download |
SDS sheet | check with sales |
Store at 2~8°C. Avoid freezing.
Maintain temperature below room temperature during transport, ensuring it does not exceed one week.